Charles Schwab Investment Management »

Xenon Pharmaceuticals shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Xenon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xenon Pharmaceuticals held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xenon Pharmaceuticals by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.6M 189k 40.15
2025-06-30 $6.0M 192k 31.30

More positions owned by Charles Schwab Investment Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Schwab Strategic Tr Fundamental Us L (FNDX)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Schwab Strategic Tr Fundamental Intl (FNDF)
Abbvie (ABBV)
JPMorgan Chase & Co. (JPM)
Home Depot (HD)
Schwab Strategic Tr Int-trm U.s Tres (SCHR)

View all positions for Charles Schwab Investment Management

Top funds holding Xenon Pharmaceuticals

FMR
venBio Select Advisor
BlackRock
Driehaus Capital Management
Henderson Group
Wellington Management Company
Braidwell
Capital Research and Management Company - Division 3
Commodore Capital
Polar Capital Holdings
Holocene Advisors
Alliancebernstein
State Street Corporation
Millennium Management
Affinity Asset Advisors

View all funds holding Xenon Pharmaceuticals